| Patents for C07D 471 - Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups (64,559) |
|---|
| 06/28/2007 | US20070149520 HCV Inhibitors And Methods Of Using Them |
| 06/28/2007 | US20070149516 to treat cellular proliferative diseases, hyperplasias, solid tumor, cardiac hypertrophy, immune disorders and inflammation; modulators of one or more mitotic kinesins; N-(2-(2-dimethylamino-acetylamino)-1-{4-[8-(1-hydroxy-ethyl)-imidazo[1,2-a]pyridin-2-yl]-benzyl}-ethyl)-3-chloro-4-isopropoxy-benzamide |
| 06/28/2007 | US20070149503 Anti-migraine spirocycles |
| 06/28/2007 | US20070149502 Spirocyclic anti-migraine compounds |
| 06/28/2007 | US20070149500 Compounds, compositions, and methods |
| 06/28/2007 | US20070149497 A tetrapyrollic photosensitizer compound having at least one pendant CH2CH2CON(CH2CON(CH2COOH)2)2 or N(CH2COOH)2 group, being a chlorin, bacteriochlorin, porphyrin, pyropheophorbide, purpurinimide, or bacteriopurpurinimide |
| 06/28/2007 | US20070149461 Use of canthin-6-one, plant extracts containing same and derivatives thereof in the treatment of trypanosomiases |
| 06/28/2007 | US20070148093 Non-terminal method of identifying anti-migraine compounds |
| 06/28/2007 | DE102005061840A1 Triazolderivate Triazole derivatives |
| 06/28/2007 | CA2634699A1 N-linked aryl heteroaryl inhibitors of lta4h for treating inflammation |
| 06/28/2007 | CA2634468A1 Spiroketals |
| 06/28/2007 | CA2633563A1 Antibacterial pyrrolopyridines, pyrrolopyrimidines, and pyrroloazepines |
| 06/28/2007 | CA2628596A1 Estrogen modulators |
| 06/28/2007 | CA2627630A1 Nicotinic acid derivatives as modulators of metabotropic glutamate receptors |
| 06/27/2007 | EP1801165A2 Modified carbocyanine dyes and their conjugates |
| 06/27/2007 | EP1801112A1 Bicyclic pyrimidines and bicyclic 3,4-dihydropyrimidines as inhibitors of cellular proliferation |
| 06/27/2007 | EP1799682A2 Reversible inhibitors of s-adenosyl-l-homocysteine hydrolase and uses thereof |
| 06/27/2007 | EP1799681A1 Condensed tricyclic benzimidazoles for the treatment of gastrointestinal disorders |
| 06/27/2007 | EP1799680A2 Triazolopyridine derivatives as antibacterial agents |
| 06/27/2007 | EP1799679A1 N,n'-dithenylurea derivatives used in the form of kinase inhibitors |
| 06/27/2007 | EP1799669A1 Heterocyclic substituted bisarylurea derivatives as kinase inhibitors |
| 06/27/2007 | EP1799216A2 Tadalafil crystal forms and processes for preparing them |
| 06/27/2007 | EP1628995B1 A process for the preparation of perindopril using tetramethyluronium salts as coupling reagents |
| 06/27/2007 | EP1485376B1 Compositions useful as inhibitors of protein kinases |
| 06/27/2007 | EP1392259B1 Delivery of erectile dysfunction drugs through an inhalation route |
| 06/27/2007 | CN1989100A Therapeutic compounds |
| 06/27/2007 | CN1988907A Dual small molecule inhibitors of cancer and angiogenesis |
| 06/26/2007 | US7235674 3-Cyano-7-methoxy-4-(3-bromo-4,5-dimethoxyphenyl)-2-oxo-2H-chromene; 7-Amino-4-(3-bromo-4,5-dimethoxy-phenyl)-3-cyano-2-imino-2H-chromene; anticancer, antitumor agent |
| 06/26/2007 | US7235670 Nitroaryl derivatives that are irradiated in the presence of a sensitizer to generate bases for controlling parallel combinatorial synthesis |
| 06/26/2007 | US7235661 Fused bicyclic aromatic compounds that are useful in treating sexual dysfunction |
| 06/26/2007 | US7235656 Anxiolytic agents with reduced sedative and ataxic effects |
| 06/26/2007 | US7235575 Guanidine mimics as factor Xa inhibitors |
| 06/26/2007 | US7235569 5-HT1A receptor antagonists and serotonin uptake inhibitors; increasing levels of serotonin in synapse and reducing latency period; psychological disorders |
| 06/26/2007 | US7235566 Pyridinone derivatives for treatment of atherosclerosis |
| 06/26/2007 | US7235557 Benzo-1,5-naphthyridine and benzo-2,5-naphthyridine derivatives are used as poly(ADP-ribose) polymerase inhibitors for treating vascular stroke, cerebral ischemia, heart ischemia/reperfusion injury and gout |
| 06/26/2007 | US7235550 Polycyclic azaindole compounds |
| 06/26/2007 | US7235545 (Calcitonin gene related peptide); azepinone ligands; migranes; 1-[(2-methoxyethyl)-2-oxo-6-phenylazepan-3-yl]-4-(2-oxo-2,3-dihydro-1H-imidazo[4,5-b]pyridin-1-yl)piperidine-1-carboxamide |
| 06/21/2007 | WO2007070826A1 Arylpropionamide, arylacrylamide, arylpropynamide, or arylmethylurea analogs as factor xia inhibitors |
| 06/21/2007 | WO2007070514A1 Heteroaryl substituted pyrrolo[2,3-b]pyridines and pyrrolo[2,3-b]pyrimidines as janus kinase inhibitors |
| 06/21/2007 | WO2007070319A2 Dibenzonaphthyridine derivatives and methods of use thereof |
| 06/21/2007 | WO2007069565A1 Bicyclic heterocyclic compound |
| 06/21/2007 | WO2007068728A2 N-substituted pyrrolopyridinones active as kinase inhibitors |
| 06/21/2007 | WO2007068641A1 Pyrrolo [2 , 3-b] pyridine derivatives as h3 receptor modulators |
| 06/21/2007 | WO2007068621A1 Novel fused pyrrole derivatives |
| 06/21/2007 | WO2007068620A1 Pyrrolo[2,3-c]pyridine derivatives |
| 06/21/2007 | WO2007068619A1 Substituted pyrazolo [4,3-c] pyridine derivatives active as kinase inhibitors |
| 06/21/2007 | WO2007068476A1 [ (1h- indol- 5 -yl) -heteroaryloxy] - (1-aza-bicyclo [3.3.1] nonanes as cholinergic ligands of the n-achr for the treatment of psychotic and neurodegenrative disorders. |
| 06/21/2007 | WO2007068475A1 (1-aza-bicyclo[3.3.1] n0n-4-yl)-[5-(ih-indol-5-yl)-heteroaryl]-amines as cholinergic ligands of the n-achr for the treatment of psychotic and neurodegenerative disorders |
| 06/21/2007 | WO2007068418A1 Use of pyrrolo [2 , 3-b] pyridines to prepare a medicament for treating pain |
| 06/21/2007 | WO2007022380A3 Bis-aryl amide compounds and methods of use |
| 06/21/2007 | WO2006133261A3 Organic compounds |
| 06/21/2007 | WO2006083440A3 Substituted chiral fused [1,2]imidazo[4,5-c] ring compounds |
| 06/21/2007 | US20070142638 Ornithine derivatives as prostaglandin e2 agonists or antagonists |
| 06/21/2007 | US20070142427 Noncyclic 1,3-Dicarbonyl compounds as dual PPAR agonists with potent antihyperglycemic and antihyperlipidemic activity |
| 06/21/2007 | US20070142415 Heteroarylpyrrolopyridinones active as kinase inhibitors |
| 06/21/2007 | US20070142414 N-substituted pyrrolopyridinones active as kinase inhibitors |
| 06/21/2007 | US20070142413 Pyrazole derivatives as inhibitors of receptor tyrosone kinases |
| 06/21/2007 | US20070142408 Compositions and methods for inhibiting TGF-Beta |
| 06/21/2007 | US20070142381 Calcium receptor modulating agents |
| 06/21/2007 | US20070142366 Jun N-terminal kinase inhibitors; 1H-pyrrolo[2,3-b]pyridines 3-substituted with a C 5-7 carbocycle and 5-substituted by a 5-member heterocycle; 3-(p-(dimethylamino)phenyl)-5-(2-thiazolyl-1H-pyrrolo[2,3-b]pyridine; neurodegenerative disorders related to apoptosis and/or inflammation |
| 06/21/2007 | US20070142365 HIV integrase inhibitors such as 5-(1,1-Dioxido-1,2-thiazinan-2-yl)-7[5-(4-fluorobenzyl)-1,3,4-oxadiazol-2-yl]-1,6-naphthyridin-8-ol, useful in the inhibition of HIV replication, the prevention and/or treatment of infection by HIV, and in the treatment of AIDS and/or ARC |
| 06/21/2007 | US20070142363 Novel diazabicyclonene derivatives and use thereof |
| 06/21/2007 | US20070142359 Pyrrolo [2,3-c] pyridine derivatives |
| 06/21/2007 | US20070142358 Pyrrolo [2,3-B] pyridine derivatives |
| 06/21/2007 | US20070142353 such as 2-(3-(aminomethyl)pyrrolidin-1-yl)-4-(4-methoxybenzyl)-7-oxo-4,7-dihydro[1,3]thiazolo[4,5-b]pyridine-6-carboxylic acid, used for treating drug-resistant bacterial infections |
| 06/21/2007 | US20070142351 Novel heterocyclic amide derivatives and their use as dopamine D3 receptor ligands |
| 06/21/2007 | US20070142350 Therapeutic uses of derivatives of piperidinyl- and piperazinyl-alkyl carbamates |
| 06/21/2007 | US20070142333 Cycloalkyl inhibitors of potassium channel function |
| 06/21/2007 | CA2637740A1 Fused pyrrole derivatives |
| 06/21/2007 | CA2635717A1 Crystalline forms of 1-benzoyl-4-[2[4-methoxy-7-(3-methyl-1h-1,2,4-triazol-1-yl)-1-[(phosphonooxy)methyl]-1h-pyrrolo[2,3-c]pyridin-3-yl]-1,2-dioxoethyl]-piperazine |
| 06/21/2007 | CA2633252A1 Arylpropionamide, arylacrylamide, arylpropynamide, or arylmethylurea analogs as factor xia inhibitors |
| 06/21/2007 | CA2632893A1 (1-aza-bicyclo[3.3.1]non-4-yl)-[5-(1h-indol-5-yl)-heteroaryl]-amines as cholinergic ligands of the n-achr for the treatment of psychotic and neurodegenerative disorders |
| 06/21/2007 | CA2632603A1 Dibenzonaphthyridine derivatives and methods of use thereof |
| 06/21/2007 | CA2632466A1 Heteroaryl substituted pyrrolo[2,3-b]pyridines and pyrrolo[2,3-b]pyrimidines as janus kinase inhibitors |
| 06/21/2007 | CA2631853A1 Substituted pyrazolo [4,3-c] pyridine derivatives active as kinase inhibitors |
| 06/21/2007 | CA2631695A1 Pyrrolo[2,3-b]pyridine derivatives as h3 receptor modulators |
| 06/21/2007 | CA2631694A1 Pyrrolo[2,3-c]pyridine derivatives |
| 06/21/2007 | CA2631654A1 [(1h-indol-5-yl)-heteroaryloxy]-(1-aza-bicyclo[3.3.1]nonanes as cholinergic ligands of the n-achr for the treatment of psychotic and neurodegenrative disorders |
| 06/21/2007 | CA2629778A1 Use of pyrrolo [2 , 3-b] pyridines to prepare a medicament for treating pain |
| 06/20/2007 | EP1798231A2 Intermediate products for the preparation of antibacterial compounds |
| 06/20/2007 | EP1798230A1 Substituted alkylamine derivatives and methods of use |
| 06/20/2007 | EP1798222A1 Binuclear metal complex, metal complex dye, photoelectric transducer and photochemical battery |
| 06/20/2007 | EP1797091A2 Imidazoquinoline compounds |
| 06/20/2007 | EP1797090A2 Sulfonamides and uses thereof |
| 06/20/2007 | EP1797089A1 Substituted tricyclic benzimidazoles |
| 06/20/2007 | EP1797054A2 Aryl-amino substituted pyrrolopyrimidine multi-kinase inhibiting compounds |
| 06/20/2007 | EP1796678A2 Carboxamide spirolactam cgrp receptor antagonists |
| 06/20/2007 | EP1796670A1 Process to prepare camptothecin derivatives and novel intermediate and compounds thereof |
| 06/20/2007 | EP1796669A2 Aminopiperidines as dipeptidyl peptidase-iv inhibitors for the treatment or prevention of diabetes |
| 06/20/2007 | EP1796664A1 Novel tetracyclic heteroatom containing derivatives useful as sex steroid hormone receptor modulators |
| 06/20/2007 | EP1796467A2 Imidazo{4,5-b}pyrazinone inhibitors of protein kinases |
| 06/20/2007 | EP1648892B1 Aryl-substituted benzo[d]isothiazol-3-ylamine analogues as capsaicin receptor modulators |
| 06/20/2007 | CN1984917A HIV integrase inhibitors: cyclic pyrimidinone compounds |
| 06/20/2007 | CN1984913A A process for the preparation of risperidone |
| 06/20/2007 | CN1984912A 有丝分裂驱动蛋白抑制剂 Mitotic kinesin inhibitors |
| 06/20/2007 | CN1984892A Urea antagonists of P2Y1 receptor useful in the treatment of thrombotic conditions |
| 06/20/2007 | CN1984660A 4-arylamino-quinazolines as activators of aspartic acid specificity cysteine protease and inducers of apoptosis |
| 06/20/2007 | CN1984655A Urea antagonists of P2Y1 receptor useful in the treatment of thrombotic conditions |
| 06/20/2007 | CN1982311A Synthesis of 2-hydrophobic-5-methoxy-diazole [4,5-b]-dipyridine |
| 06/20/2007 | CN1982310A Production of high-purity corydalis |